Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹114 Cr
Revenue (TTM)
₹92 Cr
Net Profit (TTM)
₹-20 Cr
ROE
-2.4 %
ROCE
-1.7 %
P/E Ratio
--
P/B Ratio
0.7
Industry P/E
--
EV/EBITDA
-87.9
Div. Yield
0 %
Debt to Equity
0
Book Value
₹20.2
EPS
₹-2.1
Face value
10
Shares outstanding
85,603,966
CFO
₹30.55 Cr
EBITDA
₹20.05 Cr
Net Profit
₹-26.87 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
JHS Svendgaard Lab
| -38.2 | -16.9 | 3.3 | -39.3 | -17.2 | -3.0 | -- |
|
BSE FMCG
| -2.5 | -2.5 | 7.1 | -2.7 | 14.3 | 13.5 | 10.6 |
|
BSE Small Cap
| -2.2 | 6.2 | 22.2 | 4.6 | 28.8 | 35.2 | 17.6 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
JHS Svendgaard Lab
| -16.4 | 13.9 | -18.7 | 14.6 | 56.2 | -56.3 | -54.0 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 | -23.4 |
|
BSE FMCG
| 1.5 | 27.3 | 16.6 | 9.3 | 10.5 | -3.6 | 10.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
JHS Svendgaard Lab
|
13.1 | 114.1 | 92.0 | -19.7 | -13.0 | -9.9 | -- | 0.7 |
| 104.3 | 99.8 | 2.2 | -3.3 | -50.8 | -5.7 | -- | 4.1 | |
| 2,385.4 | 64,890.3 | 6,040.2 | 1,436.8 | 29.7 | 86.6 | 45.2 | 39.0 | |
| 92.9 | 2,500.8 | 188.4 | 40.9 | 22.4 | 12.3 | 61.2 | -- | |
| 10,136.5 | 33,055.9 | 2,880.2 | 533.6 | 23.9 | -- | 61.9 | 32.3 | |
| 310.1 | 10,080.7 | 2,067.0 | 72.7 | 1.1 | 6.3 | 138.7 | 8.5 | |
| 243.3 | 15.2 | 5.9 | -0.8 | -16.6 | -- | -- | -7.4 | |
| 633.2 | 1,052.4 | 248.2 | 16.9 | 8.5 | 16.2 | 62 | 15.3 | |
| 1,913.4 | 12,180.2 | 2,708.9 | 346.9 | 13.0 | 6.1 | 35.1 | 2.1 |
No Review & Analysis are available.
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades, and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash... products, hand sanitizers, laundry detergents, room fresheners, and denture tablet products under the Dr. Gold, Dr. Fresh, Boots, Lavoris, Peanuts, Amway, Dabur, Future Group, Apollo Pharmacy, Sandika Pharma, Elder Pharma, JL Morisons, Aquawhite, 6 Ten Store, Modi Care, Infectiguard, and Odonil brands. It also provides contract manufacturing services for oral care products of other brands. The company also exports its products. JHS Svendgaard Laboratories Limited was founded in 1997 and is based in New Delhi, India. Read more
Incorporated
2004
Chairman
Rajagopal Chakravarthi Venkateish
Managing Director
Nikhil Nanda
Headquarters
Sirmour Dist, Himachal Pradesh
Website
Looking for more details about JHS Svendgaard Laboratories Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of JHS Svendgaard Laboratories Ltd stood at ₹ 201 Cr as on 31-Mar-25
The share price of JHS Svendgaard Laboratories Ltd is ₹13.05 (NSE) and ₹13.33 (BSE) as of 16-Jun-2025 IST. JHS Svendgaard Laboratories Ltd has given a return of -17.21% in the last 3 years.
JHS Svendgaard Laboratories Ltd has a market capitalisation of ₹ 114 Cr as on 16-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of JHS Svendgaard Laboratories Ltd is 0.66 times as on 16-Jun-2025, a 84% discount to its peers’ median range of 4.09 times.
Since, TTM earnings of JHS Svendgaard Laboratories Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the JHS Svendgaard Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of JHS Svendgaard Laboratories Ltd.
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades, and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, hand sanitizers, laundry detergents, room fresheners, and denture tablet products under the Dr. Gold, Dr. Fresh, Boots, Lavoris, Peanuts, Amway, Dabur, Future Group, Apollo Pharmacy, Sandika Pharma, Elder Pharma, JL Morisons, Aquawhite, 6 Ten Store, Modi Care, Infectiguard, and Odonil brands. It also provides contract manufacturing services for oral care products of other brands. The company also exports its products. JHS Svendgaard Laboratories Limited was founded in 1997 and is based in New Delhi, India.
The promoters of JHS Svendgaard Laboratories Ltd are NIKHIL NANDA and SUSHMA NANDA. They collectively own 34.53 per cent of the total equity. The chairman of the company is Rajagopal Chakravarthi Venkateish
There is no promoter pledging in JHS Svendgaard Laboratories Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
9,983
|
|
|
2,603
|
|
|
1,058
|
|
|
102
|
|
|
16
|
|
|
64,563
|
|
|
33,520
|
|
|
12,156
|
|
|
9,983
|
| JHS Svendgaard Laboratories Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
-9.91
|
|
Operating margin(%)
|
-13
|
|
Net Margin(%)
|
-20.81
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of JHS Svendgaard Laboratories Ltd was ₹-20 Cr.
₹-0.16
(
